What is FOXO4-DRI?
FOXO4-DRI is a cell-penetrating senolytic peptide that selectively targets and eliminates senescent (zombie) cells. It works by disrupting the interaction between FOXO4 and p53, causing senescent cells to undergo apoptosis while leaving healthy cells unaffected. A breakthrough in aging research.
Key Benefits & Mechanisms
Selective senescent cell elimination
Rejuvenation of aged tissues
Improved physical performance in aged models
Restoration of fur density and kidney function (animal studies)
Targeted senolytic action
Does not harm healthy cells
Potential anti-aging breakthrough
Research Summary
FOXO4-DRI made headlines from the 2017 Erasmus University study showing dramatic rejuvenation in aged mice. Senescent cells cleared from kidneys, liver, and skin. While animal data is remarkable, human clinical trials have not yet been conducted. One of the most exciting longevity research peptides.